Citigroup Inc. Boosts Stock Position in HealthEquity, Inc. (NASDAQ:HQY)

Citigroup Inc. raised its stake in HealthEquity, Inc. (NASDAQ:HQY - Free Report) by 5.3% in the 1st quarter, according to its most recent disclosure with the SEC. The fund owned 194,286 shares of the company's stock after purchasing an additional 9,798 shares during the quarter. Citigroup Inc. owned 0.22% of HealthEquity worth $17,169,000 at the end of the most recent quarter.

Several other hedge funds and other institutional investors have also recently bought and sold shares of the stock. Brown Advisory Inc. increased its stake in shares of HealthEquity by 12.0% during the fourth quarter. Brown Advisory Inc. now owns 2,086,026 shares of the company's stock valued at $200,154,000 after buying an additional 224,016 shares during the period. Northern Trust Corp grew its stake in HealthEquity by 11.7% in the fourth quarter. Northern Trust Corp now owns 1,155,043 shares of the company's stock worth $110,826,000 after purchasing an additional 121,001 shares during the period. Charles Schwab Investment Management Inc. grew its stake in HealthEquity by 1.3% in the first quarter. Charles Schwab Investment Management Inc. now owns 1,100,970 shares of the company's stock worth $97,293,000 after purchasing an additional 14,159 shares during the period. Stephens Investment Management Group LLC grew its stake in HealthEquity by 1.8% in the first quarter. Stephens Investment Management Group LLC now owns 1,069,446 shares of the company's stock worth $94,507,000 after purchasing an additional 19,009 shares during the period. Finally, Greenhouse Funds LLLP grew its stake in HealthEquity by 11.6% in the fourth quarter. Greenhouse Funds LLLP now owns 884,404 shares of the company's stock worth $84,859,000 after purchasing an additional 91,935 shares during the period. Institutional investors own 99.55% of the company's stock.

Insider Buying and Selling

In related news, EVP Elimelech Rosner sold 58,000 shares of the stock in a transaction dated Friday, June 6th. The stock was sold at an average price of $112.56, for a total transaction of $6,528,480.00. Following the completion of the sale, the executive vice president owned 75,689 shares in the company, valued at approximately $8,519,553.84. This trade represents a 43.38% decrease in their ownership of the stock. The transaction was disclosed in a document filed with the SEC, which can be accessed through this hyperlink. Also, EVP Michael Henry Fiore sold 1,794 shares of the firm's stock in a transaction that occurred on Monday, July 7th. The shares were sold at an average price of $101.73, for a total value of $182,503.62. Following the transaction, the executive vice president owned 53,225 shares of the company's stock, valued at $5,414,579.25. This represents a 3.26% decrease in their position. The disclosure for this sale can be found here. Over the last 90 days, insiders sold 291,744 shares of company stock worth $32,705,007. 1.50% of the stock is owned by corporate insiders.

HealthEquity Stock Performance

Shares of NASDAQ HQY traded up $2.46 during trading on Friday, hitting $89.89. The company had a trading volume of 894,425 shares, compared to its average volume of 838,496. The stock has a 50 day simple moving average of $98.42 and a 200 day simple moving average of $97.27. The company has a debt-to-equity ratio of 0.50, a quick ratio of 4.06 and a current ratio of 4.06. HealthEquity, Inc. has a 12 month low of $72.79 and a 12 month high of $116.65. The firm has a market capitalization of $7.77 billion, a P/E ratio of 65.61, a price-to-earnings-growth ratio of 1.39 and a beta of 0.54.

HealthEquity (NASDAQ:HQY - Get Free Report) last released its earnings results on Tuesday, June 3rd. The company reported $0.97 earnings per share (EPS) for the quarter, topping the consensus estimate of $0.81 by $0.16. HealthEquity had a return on equity of 11.01% and a net margin of 9.80%. The firm had revenue of $330.80 million during the quarter, compared to analysts' expectations of $322.25 million. During the same quarter last year, the business posted $0.80 earnings per share. As a group, analysts anticipate that HealthEquity, Inc. will post 2.32 earnings per share for the current year.

Wall Street Analysts Forecast Growth

Several equities analysts have recently weighed in on the company. Barrington Research raised their price target on HealthEquity from $112.00 to $125.00 and gave the company an "outperform" rating in a report on Thursday, June 5th. Bank of America lifted their price target on HealthEquity from $110.00 to $125.00 and gave the stock a "buy" rating in a research report on Wednesday, June 4th. Deutsche Bank Aktiengesellschaft increased their price target on shares of HealthEquity from $98.00 to $115.00 and gave the company a "buy" rating in a report on Thursday, June 5th. The Goldman Sachs Group boosted their price target on HealthEquity from $94.00 to $104.00 and gave the stock a "neutral" rating in a research note on Wednesday, June 4th. Finally, Raymond James Financial reissued a "strong-buy" rating and issued a $120.00 target price (up previously from $115.00) on shares of HealthEquity in a research report on Tuesday, July 8th. One analyst has rated the stock with a hold rating, ten have issued a buy rating and one has assigned a strong buy rating to the company. According to data from MarketBeat, HealthEquity currently has an average rating of "Buy" and a consensus price target of $118.55.

HealthEquity Company Profile

HealthEquity, Inc provides technology-enabled services platforms to consumers and employers in the United States. The company offers cloud-based platforms for individuals to make health saving and spending decisions, pay healthcare bills, receive personalized benefit information, earn wellness incentives, grow their savings, and make investment choices; and health savings accounts.